Nexalin is offering 2,315,000 shares of common stock at $4.15 per share. Nexalin will trade under the ticker name “NXL,” according to the Sept. 15 company news release.
Trading for Nexalin on the Nasdaq is set to begin Sept. 20.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
